Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in...

Area of Science:

• Thoracic Surgery
• Oncology
• Pulmonary Medicine

Background:

• The necessity of radical systematic lymphadenectomy in early-stage bronchial carcinoma remains debated.
• Current clinical guidelines lack consensus on the extent of lymph node dissection for small peripheral non-small-cell lung cancers.

Purpose of the Study:

• To prospectively evaluate the impact of radical systematic lymph node dissection versus lymph node sampling on recurrence rates and survival in patients with early-stage non-small-cell lung cancer.
• To determine if extensive lymph node dissection offers a survival benefit over sampling in this patient population.

Main Methods:

• A prospective randomized study involving 115 patients with peripheral non-small-cell lung cancers (<2 cm).
• Patients were assigned to either lobectomy with lymph node sampling (n=56) or lobectomy with radical systematic lymph node dissection (n=59).
• Outcomes assessed included local and distant recurrence rates and overall 5-year survival.

Main Results:

• No significant differences were observed in local recurrence (2 vs 2) or distant recurrence (6 vs 5) between the dissection and sampling groups, respectively.
• The 5-year overall survival rates were comparable: 81% in the dissection group and 84% in the sampling group.
• Pathologic nodal status (N1/N2) and tumor size variations did not alter the non-significant findings.

Conclusions:

• Radical systematic mediastinal and hilar lymph node dissection is not essential for clinically evaluated peripheral non-small-cell lung carcinomas smaller than 2 cm.
• Lymph node sampling appears sufficient for staging and treatment in this specific group of lung cancer patients.
• These findings suggest a less invasive approach may be appropriate, potentially reducing surgical morbidity without compromising oncologic outcomes.